Skip to main content
Top
Published in: Virology Journal 1/2010

Open Access 01-12-2010 | Short report

Association of ABO blood groups with Chikungunya virus

Authors: Naresh CVM Kumar, Mahathi Nadimpalli, Vishnu R Vardhan, Sai DVR Gopal

Published in: Virology Journal | Issue 1/2010

Login to get access

Abstract

Chikungunya virus (CHIKV) an emerging arboviral infection of public health concern belongs to the genus Alphavirus, family Togaviridae. Blood group antigens are generally known to act as receptors for various etiological agents. The studies defining the relationship between blood groups and CHIKV is limited and hence it is necessary to study these parameters in detail. In the present study 1500 subjects were enrolled and demographic data (Age, Gender, Blood group, CHIKV infection status, and CHIKV infection confirmation mode) was collected from them. The risk of acquiring CHIKV disease and its association with factors such as blood group, age and gender was analyzed statistically. The data of this study showed a possible association between blood group, age and gender of the study population with CHIKV infection. It is observed that CHIKV infections were higher in individuals with Rh positive blood group when compared to their Rh negative counterparts.CHIKV infections were found to be higher in Rh positive individuals of AB and A blood groups than that of Rh negative counterparts. Results also indicated that infections were higher in adults belonging to the age group > 30 years and also higher in males as compared to females enrolled in this study. These data present further evidence for the association of the blood groups, age and gender to susceptibility to CHIKV infection. Further studies are needed to confirm these findings. This is the second study showing the possible association of blood groups with chikungunya.
Appendix
Available only for authorised users
Literature
1.
go back to reference Moro ML, Gagliotti C, Silvi G, Angelini R, Sambri V, Rezza G, Massimiliani E, Mattivi A, Grilli E, Finarelli AC, Saptaro N, Pierro AM, Seyler T, Macini P: Chikungunya virus in North-Eastern Italy: A Seroprevalence study. Am J Trop Med Hyg 2010, 82: 508-511. 10.4269/ajtmh.2010.09-0322PubMedPubMedCentralCrossRef Moro ML, Gagliotti C, Silvi G, Angelini R, Sambri V, Rezza G, Massimiliani E, Mattivi A, Grilli E, Finarelli AC, Saptaro N, Pierro AM, Seyler T, Macini P: Chikungunya virus in North-Eastern Italy: A Seroprevalence study. Am J Trop Med Hyg 2010, 82: 508-511. 10.4269/ajtmh.2010.09-0322PubMedPubMedCentralCrossRef
2.
go back to reference Philip Samuel P, Krishnamoorthi R, Hamzakoya KK, Agarwal CS: Entamo-epidemiological investigations on Chikungunya outbreak in the Lakshadweep islands, Indian Ocean. Indian J Med Res 2009, 129: 442-445.PubMed Philip Samuel P, Krishnamoorthi R, Hamzakoya KK, Agarwal CS: Entamo-epidemiological investigations on Chikungunya outbreak in the Lakshadweep islands, Indian Ocean. Indian J Med Res 2009, 129: 442-445.PubMed
3.
go back to reference Santhosh SR, Dash PK, Parida MM, Khan M, Rao PVL: Appearance of E1: A226V mutant Chikungunya virus in Coastal Karnataka, India during 2008 outbreak. Virology Journal 2009, 6: 172. doi: 10.1186/1743-422X-6-172 10.1186/1743-422X-6-172PubMedPubMedCentralCrossRef Santhosh SR, Dash PK, Parida MM, Khan M, Rao PVL: Appearance of E1: A226V mutant Chikungunya virus in Coastal Karnataka, India during 2008 outbreak. Virology Journal 2009, 6: 172. doi: 10.1186/1743-422X-6-172 10.1186/1743-422X-6-172PubMedPubMedCentralCrossRef
4.
go back to reference Edelman R, Tacket CO, Wasserman SS, Bodison SA, Perry JG, Mangiafico JA: Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218. Am J Trop Med Hyg 2000, 62: 681-685.PubMed Edelman R, Tacket CO, Wasserman SS, Bodison SA, Perry JG, Mangiafico JA: Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218. Am J Trop Med Hyg 2000, 62: 681-685.PubMed
5.
go back to reference Powers AM, Logue CH: Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus. J Gen Virol 2007, 88: 2363-2377. 10.1099/vir.0.82858-0PubMedCrossRef Powers AM, Logue CH: Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus. J Gen Virol 2007, 88: 2363-2377. 10.1099/vir.0.82858-0PubMedCrossRef
6.
go back to reference Dhiman RC, Pahwa S, Dhillon GP, Dash AP: Climate change and threat of vector-borne diseases in India: are we prepared? Parasitol Res 2010, 106: 763-73. 10.1007/s00436-010-1767-4PubMedCrossRef Dhiman RC, Pahwa S, Dhillon GP, Dash AP: Climate change and threat of vector-borne diseases in India: are we prepared? Parasitol Res 2010, 106: 763-73. 10.1007/s00436-010-1767-4PubMedCrossRef
7.
go back to reference Labadie K, Larcher T, Joubert C, Mannioui A, Delache B, Brochard P, Guigand L, Dubreil L, Lebon P, Verrier B, Lamballerie XD, Suhrbier A, Cherel Y, Grand RL, Roques P: Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. J Clin invest 2010, 120: 894-906. 10.1172/JCI40104PubMedPubMedCentralCrossRef Labadie K, Larcher T, Joubert C, Mannioui A, Delache B, Brochard P, Guigand L, Dubreil L, Lebon P, Verrier B, Lamballerie XD, Suhrbier A, Cherel Y, Grand RL, Roques P: Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. J Clin invest 2010, 120: 894-906. 10.1172/JCI40104PubMedPubMedCentralCrossRef
10.
go back to reference Ravi V: Re-emergence of Chikungunya virus in India. Indian J Med Microbiol 2006, 24: 83-84. 10.4103/0255-0857.25175PubMedCrossRef Ravi V: Re-emergence of Chikungunya virus in India. Indian J Med Microbiol 2006, 24: 83-84. 10.4103/0255-0857.25175PubMedCrossRef
11.
go back to reference Parida MM, Santhosh SR, Dash PK, Tripathi NK, Lakshmi V, Mamidi N, Shrivastva A, Gupta N, Saxena P, Babu JP, Rao PV, Morita K: Rapid and real-time detection of Chikungunya virus by reverse transcription loop-mediated isothermal amplification assay. J Clin Microbiol 2007, 45: 351-357. 10.1128/JCM.01734-06PubMedPubMedCentralCrossRef Parida MM, Santhosh SR, Dash PK, Tripathi NK, Lakshmi V, Mamidi N, Shrivastva A, Gupta N, Saxena P, Babu JP, Rao PV, Morita K: Rapid and real-time detection of Chikungunya virus by reverse transcription loop-mediated isothermal amplification assay. J Clin Microbiol 2007, 45: 351-357. 10.1128/JCM.01734-06PubMedPubMedCentralCrossRef
12.
go back to reference Garratty G: Relationship of blood groups to disease: do blood group antigens have a biological role? Rev Med Inst Mex Seguro Soc 2005,43(Suppl 1):113-121. Garratty G: Relationship of blood groups to disease: do blood group antigens have a biological role? Rev Med Inst Mex Seguro Soc 2005,43(Suppl 1):113-121.
13.
go back to reference Behal R, Jain R, Behal KK, Dhole TN: Variation in the host ABO blood group may be associated with susceptibility to hepatitis C virus infection. Epidemiol Infect 2009. doi: 10.1017/S0950268809991117 Behal R, Jain R, Behal KK, Dhole TN: Variation in the host ABO blood group may be associated with susceptibility to hepatitis C virus infection. Epidemiol Infect 2009. doi: 10.1017/S0950268809991117
14.
go back to reference Naresh Kumar CVM, Anthony Johnson AM, Sai Gopal DVR: Molecular characterization of chikungunya virus from Andhra Pradesh, India and phylogenetic relationship with Central African isolates. Indian J Med Res 2007, 126: 534-540. Naresh Kumar CVM, Anthony Johnson AM, Sai Gopal DVR: Molecular characterization of chikungunya virus from Andhra Pradesh, India and phylogenetic relationship with Central African isolates. Indian J Med Res 2007, 126: 534-540.
15.
go back to reference National Institute of Communicable Disease, New Delhi: Chikungunya fever. CD Alert 2006, 10: 6-8. National Institute of Communicable Disease, New Delhi: Chikungunya fever. CD Alert 2006, 10: 6-8.
16.
go back to reference Lokireddy S, Sarojamma V, Ramakrishna V: Genetic predisposition to chikungunya- a blood group study in chikungunya affected families. Virology Journal 2009, 6: 77. 10.1186/1743-422X-6-77PubMedCrossRef Lokireddy S, Sarojamma V, Ramakrishna V: Genetic predisposition to chikungunya- a blood group study in chikungunya affected families. Virology Journal 2009, 6: 77. 10.1186/1743-422X-6-77PubMedCrossRef
17.
go back to reference Staikowsky F, Le Roux K, Schuffenecker I, Laurent P, Grivard P, Develay A, Michault A: Retrospective survey of Chikungunya disease in Reunion island hospital staff. Epidemiol Infect 2008, 136: 196-206. 10.1017/S0950268807008424PubMedPubMedCentral Staikowsky F, Le Roux K, Schuffenecker I, Laurent P, Grivard P, Develay A, Michault A: Retrospective survey of Chikungunya disease in Reunion island hospital staff. Epidemiol Infect 2008, 136: 196-206. 10.1017/S0950268807008424PubMedPubMedCentral
18.
go back to reference Lakshmipathy DT, Dhanasekaran D: Molecular epidemiology of Chikungunya virus in Vellore distrct,Tamilnadu,India in 2006. East Afr J Public Health 2008, 5: 122-125.PubMed Lakshmipathy DT, Dhanasekaran D: Molecular epidemiology of Chikungunya virus in Vellore distrct,Tamilnadu,India in 2006. East Afr J Public Health 2008, 5: 122-125.PubMed
19.
go back to reference Solignat S, Gay B, Higgs S, Briant L, Devaux C: Replication cycle of chikungunya: A re-emerging arbovirus. Virology 2009, 393: 183-197. 10.1016/j.virol.2009.07.024PubMedPubMedCentralCrossRef Solignat S, Gay B, Higgs S, Briant L, Devaux C: Replication cycle of chikungunya: A re-emerging arbovirus. Virology 2009, 393: 183-197. 10.1016/j.virol.2009.07.024PubMedPubMedCentralCrossRef
Metadata
Title
Association of ABO blood groups with Chikungunya virus
Authors
Naresh CVM Kumar
Mahathi Nadimpalli
Vishnu R Vardhan
Sai DVR Gopal
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2010
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-7-140

Other articles of this Issue 1/2010

Virology Journal 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.